Type 2 diabetes--delivery approaches for novel therapeutics.
Chao-Pin
Lee
L
Chao.Pin.Lee@gsk.com
Guy
Yeoman
Y
Seung Joon
Oh
O
D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control / Q000523:psychology / Q000628:therapy*; D016503:Drug Delivery Systems / Q000379:methods*; D004351:Drug Resistance; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D016381:Islets of Langerhans Transplantation; D008019:Life Style
D007004:Hypoglycemic Agents; D007328:Insulin